Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

AN Vis, FH Schröder - BJU international, 2009 - Wiley Online Library
OBJECTIVE Knowledge of the molecular and cellular changes that occur during the
transition of hormone‐naïve to castration‐resistant prostate cancer (CRPC) is increasing …
被引用次数：117 相关文章

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

AN Vis, FH Schröder - BJU international, 2009 - pubmed.ncbi.nlm.nih.gov
Objective Knowledge of the molecular and cellular changes that occur during the transition
of hormone-naïve to castration-resistant prostate cancer (CRPC) is increasing rapidly. This …

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.

AN Vis, FH Schröder - BJU International, 2009 - europepmc.org
Objective Knowledge of the molecular and cellular changes that occur during the transition
of hormone-naïve to castration-resistant prostate cancer (CRPC) is increasing rapidly. This …

Key targets of hormonal treatment of prostate cancer. Part 1: The androgen receptor and steroidogenic pathways

A Vis, F Schröder - BJU International, 2009 - repub.eur.nl
Objective: Knowledge of the molecular and cellular changes that occur during the transition
of hormone-naïve to castration-resistant prostate cancer (CRPC) is increasing rapidly. This …

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

AN Vis, FH Schroder - BJU International, 2009 - hero.epa.gov
OBJECTIVE Knowledge of the molecular and cellular changes that occur during the
transition of hormone-naive to castration-resistant prostate cancer (CRPC) is increasing …

[引用][C] Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

AN Vis, FH Schroder - BJU international, 2009 - researchinformation.amsterdamumc …
Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and
steroidogenic pathways — Amsterdam UMC research portal Skip to main navigation Skip to …

[引用][C] Key targets of hormonal treatment of prostate cancer. Part 1: The androgen receptor and steroidogenic pathways

VIS AN - BJU Int, 2009 - cir.nii.ac.jp

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.

AN Vis, FH Schröder - BJU International, 2009 - search.ebscohost.com
OBJECTIVE Knowledge of the molecular and cellular changes that occur during the
transition of hormone-naïve to castration-resistant prostate cancer (CRPC) is increasing …

[引用][C] Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

AN VIS, FH SCHRÖDER - BJU international (Papier), 2009 - pascal-francis.inist.fr
Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and
steroidogenic pathways CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

AN Vis, FH Schröder - BJU International, 2009 - cir.nii.ac.jp
Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and
steroidogenic pathways | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …